The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klugewitz, K.
Right arrow Articles by Crispe, I. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klugewitz, K.
Right arrow Articles by Crispe, I. N.
The Journal of Immunology, 2002, 169: 2407-2413.
Copyright © 2002 by The American Association of Immunologists

Immunomodulatory Effects of the Liver: Deletion of Activated CD4+ Effector Cells and Suppression of IFN-{gamma}-Producing Cells After Intravenous Protein Immunization1

Katja Klugewitz2,*,{dagger}, Friderike Blumenthal-Barby{dagger}, Arnhild Schrage{dagger}, Percy A. Knolle{ddagger}, Alf Hamann{dagger} and Ian Nicholas Crispe3,*

* Section of Immunobiology, Yale University Medical School, New Haven, CT 06520; {dagger} Experimentelle Rheumatologie, Charité, c/o Deutsches Rheumaforschungszentrum, Berlin, Germany; and {ddagger} Zentrum f. Molekulare Biologie, Heidelberg, Germany

The liver is tolerogenic in many situations, including as an allograft and during the response to allogeneic MHC expressed on hepatocytes. The majority of data that address this issue focus on endogenous Ags. Little is known about CD4+ T cells and their fate under tolerizing conditions, especially with respect to fully differentiated CD4+ effector T cells. In this study, we used the adoptive transfer of populations of TCR-transgenic CD4+ T cells, skewed toward the Th1 or Th2 phenotype, to test whether either apoptotic or immune deviation mechanisms apply to cytokine-producing CD4+ T cells that enter the liver. After transfer, Th1 and Th2 cells could be detected up to 25 days in lymphoid organs and the liver. Intravenous high dose Ag application resulted in accumulation, proliferation, and subsequent deletion of effector cells within the liver. Th1 cells lost their capacity to produce cytokines, whereas IL-4 expression was sustained within Th2 cells from the liver. However, there was no evidence for a deviation of Th1-programmed cells toward a Th2 (IL-4) or regulatory T cell (IL-10) pattern of cytokine expression. We used isolated populations of liver-derived APCs to test whether the liver had the capacity to impose a bias toward IL-4 expression in T cells. These experiments showed that liver sinusoidal endothelial cells selectively suppress the expansion of IFN-{gamma}-producing cells, yet they promote the outgrowth of IL-4-expressing Th2 cells, creating an immune suppressive milieu within this organ. These data suggest that presentation of Ags in the liver leads to modulation of immune response in terms of quantity and quality.




This article has been cited by other articles:


Home page
Int ImmunolHome page
F. Blumenthal-Barby, K. Eulenburg, A. Schrage, M. Zeitz, A. Hamann, and K. Klugewitz
In vivo modulation of antigen-experienced cells in response to high-dose oral antigen: deletion but no evidence for alterations in the cytokine phenotype
Int. Immunol., July 1, 2008; 20(7): 893 - 900.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. E. Hendrickson, T. E. Chadwick, J. D. Roback, C. D. Hillyer, and J. C. Zimring
Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells
Blood, October 1, 2007; 110(7): 2736 - 2743.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. K. Polakos, I. Klein, M. V. Richter, D. M. Zaiss, M. Giannandrea, I. N. Crispe, and D. J. Topham
Early Intrahepatic Accumulation of CD8+ T Cells Provides a Source of Effectors for Nonhepatic Immune Responses
J. Immunol., July 1, 2007; 179(1): 201 - 210.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Jennrich, B. A. Ratsch, A. Hamann, and U. Syrbe
Long-Term Commitment to Inflammation-Seeking Homing in CD4+ Effector Cells
J. Immunol., June 15, 2007; 178(12): 8073 - 8080.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Tartz, J. Kamanova, M. Simsova, P. Sebo, S. Bolte, V. Heussler, B. Fleischer, and T. Jacobs
Immunization with a Circumsporozoite Epitope Fused to Bordetella pertussis Adenylate Cyclase in Conjunction with Cytotoxic T-Lymphocyte-Associated Antigen 4 Blockade Confers Protection against Plasmodium berghei Liver-Stage Malaria
Infect. Immun., April 1, 2006; 74(4): 2277 - 2285.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Sun, B. Tumurbaatar, J. Jia, H. Diao, F. Bodola, S. M. Lemon, W. Tang, D. G. Bowen, G. W. McCaughan, P. Bertolino, et al.
Parenchymal Expression of CD86/B7.2 Contributes to Hepatitis C Virus-Related Liver Injury
J. Virol., August 15, 2005; 79(16): 10730 - 10739.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Korten, R. J. Anderson, C. M. Hannan, E. G. Sheu, R. Sinden, S. Gadola, M. Taniguchi, and A. V. S. Hill
Invariant V{alpha}14 Chain NKT Cells Promote Plasmodium berghei Circumsporozoite Protein-Specific Gamma Interferon- and Tumor Necrosis Factor Alpha-Producing CD8+ T Cells in the Liver after Poxvirus Vaccination of Mice
Infect. Immun., February 1, 2005; 73(2): 849 - 858.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. A. Rabinovich, J. Li, J. Shannon, R. Hurren, J. Chalupny, D. Cosman, and R. G. Miller
Activated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells
J. Immunol., April 1, 2003; 170(7): 3572 - 3576.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.